Osisi dị elu na-ewepụta ọkwa ọkwa ọgwụ 99% CAS 33069-62-4 Natural Paclitaxel

Ozi ngwaahịa

Aha:Paclitaxel

Nọmba CAS:33069-62-4

Usoro kemịkalụ:C47H51NO14

Nkọwapụta:99%-102%

Agba:ọcha ma ọ bụ ihe fọrọ nke nta ka ọ bụrụ ntụ ntụ ọcha

Isi mmalite:Taxus yunnanensis, Taxus chinensis

Ụdị:API

Ojiji nke paclitaxel

1. igba ogwu:ọrịa ara ara, kansa akpa ume, ọrịa ovarian

2. Ngwa ahụike:Sistemụ akwara ozi

Ngwa nke Paclitaxel

A na-eji ya na nkà mmụta ọgwụ ma jiri ya mee ihe n'ọtụtụ ebe n'ịgwọ ọrịa kansa ara, ọrịa cancer ovarian, ụfọdụ ọrịa kansa na olu na ọrịa cancer akpa ume.

Hande mmepụta okirikiri & ikike

Usoro mmepụta:Ụbọchị 45

Ike mmepụta Hande:500kg / afọ

Akụkọ ihe mere eme nke Hande GMP

1.In 1996, àgwà usoro e guzobere na nwetara DMF.

2.In 2004, FDA on-site nnyocha nwetara CGMP akwụkwọ.

3.Na 2009, ọkara-synthetic paclitaxel DMF na eke paclitaxel CEP nwetara.

4.N'afọ 2011, e nwetara paclitaxel CEP semi-synthetic.

5.In 2012, gafere nyocha TGA na saịtị, nweta asambodo GMP, wee gafee nyocha saịtị FDA.

6.In 2013, gafere CGMP saịtị.

7.In 2015, India e debara aha na Japan e debanyere aha.

Ọrụ anyị

1.Ngwaahịa:Nye elu-edu, elu-ọcha osisi wepụ, ọgwụ akụrụngwa, na ọgwụ intermediates.

2.Ọrụ nka:Mwepụta ahaziri iche nwere nkọwa pụrụ iche dị ka ihe ndị ahịa chọrọ.